VANCOUVER, BC, Oct. 3, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) – a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is proud to introduce its innovative and comprehensive psychedelic program for individuals suffering from mental distress associated with serious and chronic…


Previous articleDisposition of Common Shares of Small Pharma Inc.
Next articlePT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality, and Psychedelics